129 related articles for article (PubMed ID: 2447243)
21. Neurocatin induces changes in release and level of serotonin in synaptosomal fraction from rat brain.
Fernandez-Novoa L; Pastuszko A
Neurosci Lett; 1991 Jan; 122(1):83-6. PubMed ID: 1711660
[TBL] [Abstract][Full Text] [Related]
22. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
Sprague JE; Nichols DE
J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
[TBL] [Abstract][Full Text] [Related]
23. [Effect of MAO inhibitors on impeding synaptosomal withdrawal and on dopamine metabolism in rat and human brain].
Tóthfalusi L; Tekes K; Gaál J; Magyar K
Acta Pharm Hung; 1989; 59 Suppl 1():75-9. PubMed ID: 2641638
[No Abstract] [Full Text] [Related]
24. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
Berge OG; Fasmer OB; Tveiten L; Hole K
J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
[TBL] [Abstract][Full Text] [Related]
25. Model of central chemical 'serotoninectomy' in mice.
Herman ZS; Bonczek A
Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
[TBL] [Abstract][Full Text] [Related]
26. The effects of d-amphetamine and potassium on serotonin release and metabolism in rat cerebral cortex tissue.
Homan HD; Ziance RJ
Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):223-40. PubMed ID: 6164082
[TBL] [Abstract][Full Text] [Related]
27. Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats.
Fuller RW; Molloy BB
Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):407-18. PubMed ID: 4750092
[No Abstract] [Full Text] [Related]
28. Effects of tranylcypromine on 5-HT uptake and its interaction with PCPA on rat brain 5-HT.
Friedman E; Shopsin B; Gershon S
Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):191-4. PubMed ID: 135325
[TBL] [Abstract][Full Text] [Related]
29. Changes in serotonin metabolism in the rat brain on presentation of a habituated stimulus.
Molodtsova GF
Neurosci Behav Physiol; 2005 Jul; 35(6):561-6. PubMed ID: 16342611
[TBL] [Abstract][Full Text] [Related]
30. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
Celada P; Artigas F
J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
[TBL] [Abstract][Full Text] [Related]
31. Calcium-dependent release of endogenous serotonin, dopamine and norepinephrine from nerve endings.
Lane JD; Aprison MH
Life Sci; 1977 Feb; 20(4):665-71. PubMed ID: 839983
[No Abstract] [Full Text] [Related]
32. Serotonergic effects of isatin: an endogenous MAO inhibitor related to tribulin.
McIntyre IM; Norman TR
J Neural Transm Gen Sect; 1990; 79(1-2):35-40. PubMed ID: 1688707
[TBL] [Abstract][Full Text] [Related]
33. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
[TBL] [Abstract][Full Text] [Related]
34. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
[No Abstract] [Full Text] [Related]
35. Methadone inhibition of 3H-5-hydroxytryptamine uptake by synaptosomes.
Ciofalo FR
J Pharmacol Exp Ther; 1974 Apr; 189(1):83-9. PubMed ID: 4823302
[No Abstract] [Full Text] [Related]
36. Comparative effects of 5,6-dihydroxytryptamine and its benzo[b]-thiophene analogue on biogenic amines in the rat.
Donelson AC; Bosin TR; Campaigne E; Rogers RB; Maickel RP
Biochem Pharmacol; 1979 Nov; 28(22):3339-43. PubMed ID: 526340
[No Abstract] [Full Text] [Related]
37. The effect of in vivo deprenyl on cerebral amine system in rats with portocaval shunts.
Fogel WA; Andrzejewski W; Sasiak K; Maslinski C
Inflamm Res; 2000 Apr; 49 Suppl 1():S45-6. PubMed ID: 10864416
[No Abstract] [Full Text] [Related]
38. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
39. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.
Roth JA; Gillis CN
Biochem Pharmacol; 1974 Sep; 23(18):2537-45. PubMed ID: 4412708
[No Abstract] [Full Text] [Related]
40. Inhibitory effects of type A and type B monoamine oxidase inhibitors on synaptosomal accumulation of [3H]dopamine: a reflection of antidepressant potency.
Azzaro AJ; Demarest KT
Biochem Pharmacol; 1982 Jun; 31(12):2195-7. PubMed ID: 7115440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
